India has issued new clinical trial rules that specify time-bound regulatory approvals and provide for local trial exemptions for drugs approved in certain developed countries, subject to specific conditions.
The new rules are also shed certain contentious trial compensation provisions that were part of a previous draft regulation and had made sponsors nervous.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?